Search research articles
Contact Us
Filters
Showing results (1-10 of 69) with videos related to
Page
of 7
Sort By:
Acta Neuropathologica Communications
|
February 1, 2021
Neuroligin-1 in brain and CSF of neurodegenerative disorders: investigation for synaptic biomarkers
Elena Camporesi, Tammaryn Lashley, Johan Gobom, et al.
Alzheimer'S Research & Therapy
|
October 12, 2023
Blood biomarkers and neurodegeneration in individuals exposed to repetitive head impacts
Charles Bernick, Guogen Shan, Aaron Ritter, et al.
Communications Biology
|
November 5, 2021
Truncating tau reveals different pathophysiological actions of oligomers in single neurons
Emily Hill, Thomas K Karikari, Juan Lantero-Rodriguez, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
February 28, 2022
CSF biomarkers and plasma p-tau181 as predictors of longitudinal tau accumulation: Implications for clinical trial design
Alexis Moscoso, Thomas K Karikari, Michel J Grothe, et al.
Neurology
|
July 16, 2021
Associations of Fully Automated CSF and Novel Plasma Biomarkers With Alzheimer Disease Neuropathology at Autopsy
Michel J Grothe, Alexis Moscoso, Nicholas J Ashton, et al.
Acta Neuropathologica Communications
|
April 24, 2023
Tau in cerebrospinal fluid induces neuronal hyperexcitability and alters hippocampal theta oscillations
Jessica Brown, Elena Camporesi, Juan Lantero-Rodriguez, et al.
Brain : a Journal of Neurology
|
December 1, 2020
Time course of phosphorylated-tau181 in blood across the Alzheimer's disease spectrum
Alexis Moscoso, Michel J Grothe, Nicholas J Ashton, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)
|
June 14, 2021
Effects of pre-analytical procedures on blood biomarkers for Alzheimer's pathophysiology, glial activation, and neurodegeneration
Nicholas J Ashton, Marc Suárez-Calvet, Thomas K Karikari, et al.
Acta Neuropathologica
|
July 29, 2020
Plasma p-tau181 accurately predicts Alzheimer's disease pathology at least 8 years prior to post-mortem and improves the clinical characterisation of cognitive decline
Juan Lantero Rodriguez, Thomas K Karikari, Marc Suárez-Calvet, et al.
Alzheimer'S Research & Therapy
|
January 9, 2021
Association between polygenic risk score of Alzheimer's disease and plasma phosphorylated tau in individuals from the Alzheimer's Disease Neuroimaging Initiative
Anna Zettergren, Jodie Lord, Nicholas J Ashton, et al.
Page
of 7
Search research articles
Search
Showing results (1-10 of 69) with videos related to
Sort By:
Page
of 7
Acta Neuropathologica Communications
|
February 1, 2021
Neuroligin-1 in brain and CSF of neurodegenerative disorders: investigation for synaptic biomarkers
Elena Camporesi, Tammaryn Lashley, Johan Gobom, et al.
Alzheimer'S Research & Therapy
|
October 12, 2023
Blood biomarkers and neurodegeneration in individuals exposed to repetitive head impacts
Charles Bernick, Guogen Shan, Aaron Ritter, et al.
Communications Biology
|
November 5, 2021
Truncating tau reveals different pathophysiological actions of oligomers in single neurons
Emily Hill, Thomas K Karikari, Juan Lantero-Rodriguez, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
February 28, 2022
CSF biomarkers and plasma p-tau181 as predictors of longitudinal tau accumulation: Implications for clinical trial design
Alexis Moscoso, Thomas K Karikari, Michel J Grothe, et al.
Neurology
|
July 16, 2021
Associations of Fully Automated CSF and Novel Plasma Biomarkers With Alzheimer Disease Neuropathology at Autopsy
Michel J Grothe, Alexis Moscoso, Nicholas J Ashton, et al.
Acta Neuropathologica Communications
|
April 24, 2023
Tau in cerebrospinal fluid induces neuronal hyperexcitability and alters hippocampal theta oscillations
Jessica Brown, Elena Camporesi, Juan Lantero-Rodriguez, et al.
Brain : a Journal of Neurology
|
December 1, 2020
Time course of phosphorylated-tau181 in blood across the Alzheimer's disease spectrum
Alexis Moscoso, Michel J Grothe, Nicholas J Ashton, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)
|
June 14, 2021
Effects of pre-analytical procedures on blood biomarkers for Alzheimer's pathophysiology, glial activation, and neurodegeneration
Nicholas J Ashton, Marc Suárez-Calvet, Thomas K Karikari, et al.
Acta Neuropathologica
|
July 29, 2020
Plasma p-tau181 accurately predicts Alzheimer's disease pathology at least 8 years prior to post-mortem and improves the clinical characterisation of cognitive decline
Juan Lantero Rodriguez, Thomas K Karikari, Marc Suárez-Calvet, et al.
Alzheimer'S Research & Therapy
|
January 9, 2021
Association between polygenic risk score of Alzheimer's disease and plasma phosphorylated tau in individuals from the Alzheimer's Disease Neuroimaging Initiative
Anna Zettergren, Jodie Lord, Nicholas J Ashton, et al.
Page
of 7